MicroPhage's MRSA test detects bacteria within five hours
This article was originally published in Clinica
A test developed by diagnostics firm MicroPhage can detect Staphylococcus aureus within five hours, the Longmont, Colorado company claims. The test requires two tubes, one to determine whether the sample contains S aureus, and the other to ascertain whether the strain is antibiotic-resistant (MRSA). Patients can then be treated accordingly. MicroPhage hopes to launch the test in late 2009. Other firms to have rapid MRSA tests approved recently include Cepheid and Becton Dickinson – their tests give results within two hours, whereas traditional blood culture methods can take up to two days.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.